BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Smiths Group Raises Additional Long Term Debt Capital


2/26/2009 11:38:50 AM

LONDON--(Marketwire - February 26, 2009) - Smiths Group plc ("Smiths") announced today that it has completed the raising of additional long-term debt capital from the issue of US$175m of Senior Notes ("Notes") in the US private placement market with a fixed 9 year maturity and a fixed coupon of 7.37%, the coupon having been set earlier in the year.

Smiths will use the proceeds from the Notes for general corporate purposes and to repay short-term borrowings drawn from committed bank facilities. These committed bank facilities are available to Smiths until June 2012 and will continue unchanged.

The Notes have been issued by Smiths and have been co-guaranteed by Smiths Group International Holdings Limited. The Notes will rank pari passu with all Smiths' existing unsecured indebtedness.

The Notes have been purchased by a single debt investor, Pricoa Capital Group, which is an existing investor in Smiths through its participation in the US$250m Senior Notes maturing in 2013.

John Langston, Finance Director of Smiths Group, said "We are delighted to have completed this debt financing at the same time as extending our long term relationship with a leader in the US private debt market. This transaction increases liquidity at the Group and significantly extends the maturity of our debt".

Marie Fioramonti, managing director, Pricoa Capital Group said, "Smiths Group is an investment-grade company that we know well and like. Its diversified range of businesses, both by geography and sector, provide underlying security and predictable cash flows, well-suited for a long-term private placement. We are delighted to be continuing our relationship with Smiths"

About Smiths Group

Smiths is a global technology company listed on the London Stock Exchange. A world leader in the practical application of advanced technologies, Smiths Group delivers products and services for the threat & contraband detection, energy, medical devices, communications and engineered components markets worldwide. Our products and services make the world safer, healthier and more productive.


Investor Relations
Peter Durman
+44 (0)20 7808 5535
+44 (0)7825 145336

Media
Colin McSeveny
+44 (0)20 7808 5534

Anthony Cardew
Cardew Group
+44 (0)20 7930 0777



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES